Biotechnology companies can use “value-chain analysis” to create processes for maximizing the value of their intellectual property portfolios, say Bill Barrett and Dave Crawford. Every ...
Protectionist policies will raise the prices of active ingredients for these producers, many of whom may have little recourse ...
Tony Townley and Zach McLeroy met in middle school in Athens, Georgia. They’re now both billionaires from Zaxby’s, the fried ...
On March 31st Goldman Sachs raised the odds of one from 20% to 35%. JPMorgan Chase now puts those of a global downturn this ...
TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been named ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed ('HBM' or the 'Company'; ...
Companies specializing in drug development inputs and services play a crucial role in the pharmaceutical and biotechnology value chain. Essential support for drug discovery, preclinical testing ...
For more than three decades, the pharmaceutical sector has been protected from tariffs by a World Trade Organization ...
Total deal value of innovator drug licensing agreements involving Chinese biopharma licensors has risen 66% to $41.5 billion ...
Companies specializing in drug development inputs and services play a crucial role in the pharmaceutical and biotechnology value chain. Essential support for drug discovery, preclinical testing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback